Application of breast lump-elimination preparation in preparing medicines for treating dysmenorrhea
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of Rupixiao and preparation, which is applied in directions such as drug combinations, antipyretics, anti-inflammatory agents, etc., can solve the problems such as the undisclosed treatment of primary dysmenorrhea or secondary dysmenorrhea, the undisclosed Rupixiao treatment of dysmenorrhea and the like.
Active Publication Date: 2011-05-04
哈尔滨泰华药业股份有限公司
View PDF3 Cites 8 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there is no disclosure in the prior art that Rupixiao has the effect of treating dysmenorrh...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0034] Preparation of Rupixiao Extract:
[0035] 44.5 parts by weight of dandelion, 173.5 parts by weight of kelp, 17.8 parts by weight of trichosanthin, 44.5 parts by weight of Mildew Spatholobus
[0036] 13.4 parts by weight of Paeoniae Rubra, 86.8 parts by weight of seaweed, 26.7 parts by weight of Leulu, 35.6 parts by weight of woody fragrance
[0037] 62.3 parts by weight of paeonol, 44.5 parts by weight of Prunella vulgaris, 17.8 parts by weight of forsythia, 26.7 parts by weight of safflower
[0038] Antlers 66.8 parts by weight Sanqi 44.5 parts by weight Scrophulariaceae 44.5 parts by weight,
[0039] Take Scrophulariaceae, Panax notoginseng, and antlers, mix them and grind them to get fine powder for later use;
[0040] Take dandelion, kombu, trichosanthum pollen, millet root, red peony root, seaweed, leaking reed, woody fragrance, peony bark, prunella vulgaris, forsythia, safflower, add water to decoct twice, add 8-12 times the amount of water for the first time ,...
Embodiment 2
[0042] The Rupixiao extract prepared in Example 1 was added with appropriate excipients, and prepared into granules according to the conventional process, and each 8 g of granules was equivalent to 6 g of the original medicinal material.
Embodiment 3
[0044] The Rupixiao extract prepared in Example 1 was added with appropriate excipients, and prepared into tablets according to a conventional process.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the application of a breast lump-elimination preparation in preparing medicines for treating dysmenorrheal. The breast lump-elimination preparation is prepared from antler, dandelion, laminaria, Mongolian snakegourd root, suberect spatholobus stem, pseudo-ginseng, red peony root, seaweed, uniflower swisscentaury root, costustoot, figwort root, the root bark of the peony tree, prunella, weeping forsythia and red flower. Proved by pharmacodynamic experiments, breast lump-elimination granules not only have an obvious anti-inflammatory abirritation effect, but also have an obvious effect on inhibiting uterus super contraction induced by oxytocin. In clinical researches, the breast lump-elimination preparation can alleviate the clinical symptoms of primary dysmenorrheal patients when being used for treating mammary gland lobular hyperplasia, and has the characteristics of fast effect-taking, durable action and fewer adverse reactions when being used for treating the primary dysmenorrheal, and has certain effect on treating secondary dysmenorrheal.
Description
technical field [0001] The present invention relates to the new application of Rupixiao preparation, in particular to the application in preparing medicine for treating dysmenorrhea. Background technique [0002] Dysmenorrhea is divided into two types: primary and secondary. The main manifestations are: women experience lower abdomen or waist pain, or even pain in the lumbosacral area, during menstruation or before and after menstruation. Cold sweat, cold hands and feet, and even fainting. This dysmenorrhea accompanying menstrual period is the most common gynecological disease among adolescent women and women of childbearing age, and is a common cause affecting women's normal work and physical and mental health. In China, as early as 1978, the National Women's Menstrual Physiological Constant Cooperative Group investigated and analyzed the menstrual frequency of more than 130,000 women in 29 provinces, municipalities, and autonomous regions. Dysmenorrhea accounted for 33.19...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more